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Summary
Objective: To characterise in vitro engineered cartilaginous constructs made employing a novel static, scaffold-free and closed chamber
system.
Design: Chondrocytes derived from slaughter age pigs (3–6 months) were seeded at high density (20×106) into cylindrical chambers
(1.0×0.5 cm) and were maintained between an upper and a lower membrane (100 kDa) for 21 days and subsequently cultured in open
culture for 7 additional days.
Results: Viable constructs produced were approximately 10 mm×2 mm in size and were stable enough to be handled by surgical pincers.
Histology and electron microscopy evaluations revealed a neo-cartilage structure of high cell density with a comprehensive extracellular
matrix. Predominately collagen type II and negligible amounts of collagen types I and X were detected using RT-PCR and SDS-PAGE
analyses.
Conclusions: In this study, we provide evidence of a scaffold-free system that can produce immature hyaline-like cartilaginous constructs
suitable for in vivo implantation, or that may be useful for in vitro studies of events related to the process of chondrogenesis.
© 2003 Published by Elsevier Science Ltd on behalf of OsteoArthritis Research Society International.
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Introduction
Close cell interaction in a three-dimensional (3D) con-
figuration appears to be a major requirement for the initia-
tion of chondrogenesis in vitro1–4, for chondrocyte survival5
and to drive bone marrow stromal and mesenchymal cells
towards cartilage6,7. Coupled with the apparent pre-
requisite of a 3D seeding platform is the requirement of
conditions that allow the synthesis and aggregation of
extracellular matrix (ECM) molecules (proteoglycans and
collagens), which may otherwise be lost to the in vitro
environment8. Loss of such molecules may even lead to
apoptosis9.
Chondrocyte culture in vitro has been reported since the
1960s10, and the process of chondrogenesis has been
documented in vitro under numerous 3D microenviron-
ments and perfusion programmes. Horwitz and Dorfman11
observed that chondrocytes maintained in soft agar pro-
duced matrix. Benya and Shaffer12 demonstrated that
chondrocytes previously maintained in monolayer could
revert to the chondrocyte phenotype when cultured in
agarose gels and synthesise matrix-associated products.
Since, a variety of other materials have been trailed to
revert or maintain the chondrogenic phenotype, including
alginate13–15, collagen gels16, fibre fleece scaffolds of poly-
hydroxy acids17–21, fibrin gels22 and hyaluronic acid
carriers/sponges23,24. Combinations of these materials
have also been utilised, such as polymer fleece cultures
that are coated with a gel or semi-permeable membranes,
to help retain matrix components20. In the field of ortho-
paedics, many of these substances have been the focus of
groups striving to produce artificial cartilaginous constructs,
especially as means of producing an implant for use in
repairing articular defects19,25,26.
All of the earlier-mentioned systems have been demon-
strated to create permissive conditions for the process of
chondrogenesis and to create de novo tissue consistent, at
least biochemically, with cartilaginous tissue. However, a
majority of these methods are cumbersome, technically
demanding and require the service of a scaffold. In view of
the goal to produce cartilaginous constructs for in vivo
implantation for repair of articular defects, a system that
produces suitable implants with the most basic of conditions
is thus desirable. Hence, the aim of the present study
was to evaluate chondrogenesis in the protective environ-
ment of a simple closed chamber system that does
not employ a scaffold or any complicated perfusion
technologies.
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Methods and materials
PRIMARY CULTURE AND CULTURE CONDITIONS
Full thickness porcine articular cartilage was har-
vested aseptically from the medial and femoral condyles of
slaughter age pigs (3–6 months; N12) using pronase
(2 h in 1 mg/ml, 10 ml/g of tissue; Roche, Switzerland)
and collagenase digestion (15 h in 0.25 mg/ml, 10 ml/g of
tissue; Roche, Switzerland) and was directly seeded at a
density of 20 million cells into DeNovo™ dialysis cham-
bers27 [Fig. 1(A, B)]. The cells were maintained between
the upper and lower membranes (100 kDa) for 21 days
and were subsequently cultured out of the chamber in
six well plates (in free open culture) for further 7 days.
Each chamber occupied one well of a six well plate
(NUNCLON; Nunc, Denmark) with approximately 10 ml
of DMEM media supplemented with 10% FCS (Life
Technologies, HyClone, UT, USA), insulin (1 µg/ml; Life
Technologies), vitamin C (50 µg/ml; Fluka, Switzerland)
and maintained at standard conditions (37°C, 5% CO2
and 90% humidity). The media in each well was changed
every 2 or 3 days.
OVERVIEW OF CONSTRUCT ANALYSES
If not indicated otherwise, each analysis relied on six
different construct equivalents. All constructs were photo-
graphed to record the size and gross morphology, before
each construct was processed to establish wet and dry
weight, cell number, construct viability (live/dead test), apop-
tosis (TUNEL), gene expression (reverse transcriptase
(RT)-PCR collagen I and II), SDS-PAGE (collagen and GAG
characterisation), histology (alcian blue, Masson trichrome,
safranin-O, haematoxylin–eosin), morphometric analyses
and for transmission electron microscopy.
Fig. 1. (A) The DeNovo™ closed chamber system. (I) The top and base that supports the (II) inner chambers, which come in two inner
diameter sizes. (III) Base support with membrane and inner chamber. The membrane is held in place between the lower base and the inner
chamber. Cells are then seeded into this space, followed by an upper membrane that is then held in place by adding the top support. (IV)
A completely constructed closed chamber system with the upper and lower membranes in place. (B) Mechanism of neo-cartilage formation.
The cells are seeded at high density between semi-permeable membranes that protect the developing construct from turbulence and the loss
of new matrix-associated molecules during media changes.
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GROSS MORPHOLOGY
Each construct was removed from the media and was
photographed to indicate the construct appearance. The
diameter of each construct (D) was calculated from the flat
circular area assessed using an inverted microscope with
an attached digital camera (Nikon Diapact 300, Japan) and
imaging software (Image-Pro Plus, Media Cybernetics,
MD, USA).
HISTOLOGY
Construct pieces designated for histological evaluation
were fixed for 24 h in 4% paraformaldehyde and were
subsequently embedded in paraffin. Haematoxylin–eosin,
alcian blue (acid), Masson trichrome and safranin-O
fast green staining were performed on each construct
produced.
HISTOMORPHOMETRIC ANALYSES
Construct organisation and thickness were assessed by
image using a light microscope (Leica, Germany) con-
nected to a video camera (Kappa CF20DX, Germany) and
image analysis software (Image-Pro Plus, Media Cyber-
netics). Spatial distributions of cells within constructs were
assessed by image analysis of alcian blue-stained cross-
sections. Digital pictures were acquired using the system
described earlier, and fields measuring 0.25 mm2 were
randomly chosen and classified as either central (C) or
peripheral (P), depending on whether the region was more
or less than 0.5 mm from the outer construct surface,
respectively. In each field, the number of cells was deter-
mined by counting the red stained nuclei. The average cell
density per square millimetre in at least five different
constructs was calculated from at least 10 central or
peripheral fields.
ENZYMATIC CELL ENUMERATION
Construct equivalents were subjected to collagenase
(1 mg/ml; Roche, Switzerland) for 30–60 min to obtain
single cells. Cell number was determined using an auto-
mated cell counter (CASY1, Scha¨rfe System GmbH,
Reutlingen, Germany) and was expressed as cell number
per gram wet weight.
CELL VITALITY
Enzymatic analyses
The viability of single cells was assessed by using a
two-colour fluorescence cell viability assay (Molecular
Probes Inc., Eugene, OR, USA). Briefly, cells attached to
poly-L-lysine coated slides were stained with calcein-AM
(indicative of living cells by conversion of this non-
fluorescent membrane-permeable substrate into a
membrane-non-permeable green fluorophore by an intra-
cellular esterase activity) and with ethidium homodimer
(nucleic acid stain indicative of membrane-permeable dead
cells) and visualised by fluorescence microscopy. Three
different areas were chosen randomly and were evaluated
with the Image-Pro Plus software (Media Cybernetics).
Whole tissue (confocal microscopy)
Sections of construct were embedded in agar (gelling
temperature approximately 35°C; Fluka) while being cut
with a tissue sectioner (TC-2 Smith and Farquhar, Ivan
Sorval Inc., CT, USA), producing 230 µm sections. The
sections were maintained in PBS before incubation at room
temperature for 1 h in the live/dead reagent consisting of
ethidium homodimer (8 µM) and calcein-AM (1 µM) in PBS
(Molecular Probes). The sections were viewed under laser
confocal microscopy (LSM 410, Zeiss, Germany) using
excitation wavelengths of 488 nm, and both red and green
fluorescence images were detected simultaneously to
assess the proportion of live and dead cells in the section
(random fields, different focal points and magnifications).
Apoptosis
The in situ cell-death detection POD kit (Roche
Molecular Biochemicals, Germany) was used to detect
apoptotic cells (in terms of DNA strand breaks) in paraffin-
embedded samples. The manufacturer’s protocol was fol-
lowed, which briefly entailed dewaxing and rehydration of
10 µm cut sections, washing with PBS and treatment with
proteinase K (20 µg/ml in 10 mM Tris/HCl) for 30 min at
37°C. The slides were then incubated in blocking solution
(3% H2O2 in methanol) for 10 min at room temperature and
were permeabilised (0.1% Triton X-100 in 0.1% sodium
citrate) for 2 min on ice. Following incubation with the
TUNEL reaction mixture, the slides were kept at 37°C for
60 min and were viewed under a fluorescence microscope
(excitation wavelength of 488 nm to visualise green fluores-
cence). The fluorescence signal was converted for visuali-
sation under the light microscope using the converter-POD
solution supplied. Negative controls consisted of samples
exposed to the label solution without the terminal trans-
ferase instead of the TUNEL reaction mixture. Positive
controls were made by incubating some slides with 1 mg/ml
of DNase I for 10 min at room temperature. TUNEL positive
signals were assessed by random field (5) examinations on
a 40× objective lens. The number of TUNEL positive cells
was expressed as a percentage of total cells in each field.
GENE EXPRESSION (SEMI-QUANTITATIVE PCR)
A portion (approximately 30 mg) of construct was stored
in liquid nitrogen for collagen types I and II, decorin,
aggrecan, biglycan, versican and glyceraldehydes-3-
phosphate dehydrogenase (GAPDH) gene expression
analyses. The frozen construct portions were pulverised by
mortar and pestle on liquid nitrogen prior to addition of the
lysis buffer supplied as part of the RNeasy kit (Qiagen AG,
Basel, Switzerland).
Total RNA from the constructs was isolated using the
RNeasy mini kit (Qiagen). The extracted RNA was reverse-
transcribed using the RT Omniscript (Qiagen) with
the incubation buffer and the instructions provided by the
manufacturer. The cDNA (5 µl) obtained was used for the
subsequent PCR experiments whereby the high fidelity Taq
polymerase (Roche Diagnostics Rotkreuz, Switzerland)
was used together with 200 µM dNTPs and 0.25 µM each
of sense and antisense primers (see Table I). Standard
curves to determine the exponential/linear phase of product
amplification revealed that 24 cycles were optimal. After 24
cycles (30 s at 94°C, 30 s at the annealing temperature and
30 s at 72°C), the PCR products were loaded on a 2%
agarose gel and visualised under UV light after ethidium
bromide staining. As control, the housekeeping gene
coding GAPDH was amplified.
Gel images were captured electronically under UV light
with a video-documentation system (Eastman Kodak Co.,
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DC120 zoom digital camera, New Haven, CT, USA), and
the bands were quantified using the image analysis soft-
ware ImageQuaNT version 5.0 (Molecular Dynamics, Little
Chalfont, Buckinghamshire, UK). The level of each gene of
interest was determined with reference to GAPDH.
BIOCHEMICAL ANALYSES
Total collagen
Total collagen content of each construct was determined
spectrophotometrically from the hydroxyproline content
after alkaline hydrolysis (4 M NaOH, 120°C, 30 min)
and reaction with p-dimethylaminobenzaldehyde and
chloramine T28 using a calibration curve with known
concentrations of gelatin.
Characterisation of different collagen types
To distinguish between individual collagen types, the
method described by Schwartz et al.28 was used. Briefly,
the samples were homogenised with a grinding mill
(6750 Freezer Mill, SPEX Industries GmbH, Grasbrunn,
Germany) and were then subjected to repeated digestion
with pepsin (1 mg/ml, 24 h, 4°C; Sigma, Switzerland) in
0.5 M acetic acid, 0.2 M NaCl, pH 1.5. After neutralisation
of the pooled digests, solubilised collagens were precipi-
tated in 4.5 M NaCl. The salt-precipitated collagens were
separated by 4.5–15% gradient gel electrophoresis, paral-
lel with standards of pure collagens I, II, IX, X and XI.
Proteoglycan content
Following pretreatment of each sample with papain
(1 mg enzyme per 500 mg tissue in 1 M NaCl, 0.05 M
sodium phosphate, 5 mM cysteine–HCl, 10 mM EDTA,
pH 6.5) for 30 min at 60°C, the digests were subjected to
two consecutive extraction steps (24 h, 4°C) with 10 vol-
umes of 4 M guanidium chloride, 0.05 M sodium acetate,
pH 5.8. Total proteoglycan content of pooled extracts was
measured using the colorimetric dimethylene blue (DMB)
assay for sulphated glycosaminoglycans29. The results
are reported with reference to equivalents obtained from
standard purified chondroitin sulfate from shark.
IMMUNOHISTOCHEMISTRY (COLLAGEN TYPES I, II AND X)
Tissue samples were fixed for 24 h with 4% paraformal-
dehyde, embedded in paraffin and were cut into 4 µm thick
sections. After pretreatment with 1 mg/ml chondroitinase,
sections were incubated with monoclonal primary anti-
bodies for collagen type I (Quartett, Berlin, Germany),
collagen type II (II-II6B3, Hybridoma Bank, University of
Iowa, USA) or collagen type X (Quartett) for 1 h. The slides
were then incubated with a biotinylated goat anti-mouse
secondary antibody for 35 min followed by StrABC/AP for
45 min (DAKO, Denmark). Bound antibodies were made
visible by means of New Fuchsin/Naphthol AS-BI substrate
(Sigma Chemical Co., Switzerland).
ELECTRON MICROSCOPY
The fixation method using ruthenium hexamine tri-
chloride (RHT) outlined by Hunziker et al.30 was followed.
Sections, 1 µm thick, were stained with toluidine blue for
sample assessment and orientation. Subsequently, 80 nm
thick sections were contrasted with uranyl acetate followed
by lead citrate prior to observation on a transmission
electron microscope (E10, Zeiss).
STATISTICS
Comparisons between the numbers of nuclei located
either centrally or peripherally in the morphometrically
assessed constructs were made using a Student’s t-test.
Results
There was evidence of matrix accumulation within the
bioreactor by day 5, observed by illumination of the
chamber under an inverted microscope. After 21 days in
the bioreactor chamber, the cartilaginous constructs pro-
duced were stable enough to be handled using surgical
pincers. The constructs formed were 10.7±0.4 mm in
diameter and 2.2±0.5 mm in thickness, with a regular
cylindrical shape and the macroscopic appearance of
immature cartilage [Fig. 2(A)]. Confocal live/dead analysis
revealed that the constructs produced were highly viable
[Fig. 2(B)] with approximately 90% of the cells alive (green)
and 10% dead (red), consistent with enzyme viability analy-
sis and TUNEL apoptosis results (Table II). TUNEL positive
cells were observed mainly concentrated in the immediate
central region of the implant and the outer layer. Little cell
death (pycnotic bodies) was noted in the morphological
analysis in most cases, but if present, it was more intense
in the outer layers.
Histological staining revealed a high cell density and
substantial matrix accumulation. Alcian blue staining
[Fig. 2(C)] and safranin-O staining [Fig. 2(D)] showed that
the matrix produced consisted mainly of glycosaminogly-
cans in agreement with the biochemical analyses (Table II).
Safranin-O homogeneously stained almost the entire
Table I
PCR primers
Gene Primer sense Primer antisense Annealing temperature (°C)†
Collagen type I alpha CTGGTGATGCTGGTCCTGTTG CCTTGGGGTTCTTGCTGATGT 54
Collagen type II alpha CCGCCTTTGCTGGCTTAGGCCCG CCACCATTGATGGTTTCTCCAAACC 56
Decorin CTCCTACATCCGCATTGCTG GCGCACGTAGACACATCTGA 55
Aggrecan CCTCAGGACTTCCAGAAGTT ACTGGTGGTGGTGGATTCTC 52
Biglycan CAACGGCATCAGCCTCTTCA ACTGGAGCCTTGGACACTTG 54
Versican CGGAGGCACCTGTTATCCTA CCATCAGTCCAACGGAAGTC 53
GAPDH CTGCCCCTTCTGCTGATGCC CATCACGCCACAGTTTCCCA 57
†Calculated with the ‘Oligonucleotide Properties Calculator’, developed using the nearest-neighbour method, which can be accessed on
the web page http://www.basic.nwu.edu/biotools/oligocalc.html.
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tissue-engineered construct with the exception of a thin
outer layer of less than 3 µm. Histomorphometry revealed
higher cell densities in central regions than in peripheral
regions (Table II; P<0.001). The examination of Masson
trichrome slides under polarised light did not identify
collagen fibre orientation. Immunohistochemical analysis
revealed a uniform and intense staining of the matrix with
antibodies against collagen type II. Collagen types I and X
were not detected at the protein level. Transmission
electron micrographs [Fig. 2(E)] show the formation of
interterritorial zones and matrix ultrastructure products,
such as collagen and proteoglycans [Fig. 2(F)].
Biochemical analyses indicated that the majority of the
collagen formed by day 28 was collagen type II (Fig. 3).
Moreover, semi-quantitative PCR analyses (at 7 days)
reflected the biochemical data with similar proportional
differences in collagen types I and II expression levels
(Fig. 4). Collagen type I expression was only detected in
two of five constructs examined, with a relatively (with
regard to GAPDH) low expression value of 0.14±0.03
(mean±S.E.M.). Collagen type II expression levels were
much higher (0.98±0.04), as were those of decorin
(0.57±0.04). Biglycan expression was moderate
(0.39±0.04), whereas aggrecan expression was detected
Fig. 2. (A) Macrophotograph of neo-cartilage formed after 28 days of culture; (B) confocal live/dead image; (C) alcian blue histology stain;
(D) safranin-O histology stain; (E) electron micrograph showing chondrocytes, interterritorial zone formation and matrix deposition;
(F) electron micrograph of collagen fibrils and aggregates of proteoglycan.
Table II
Biochemical characterisation of neo-cartilage constructs (DeNovo) cultured for 28 days with some comparative data from native porcine
cartilage (mean±standard deviation)
DeNovo (N=6) Native cartilage Proportion DeNovo:native
Diameter (mm) 10.7±0.4
Thickness (mm) 2.2±0.5
Wet weight (mg) 90.5±14.48
Dry weight (mg) 7.8±1.71† 24.2±2.47† 1:3
Cell number
per gram 116.9±34.53
per wet weight 10.6±3.41
Morphometrics
Average number of cell peripherally 520.9±36.7‡
Average number of cell centrally 954.7±56.4‡
Cell viability
Isolated (% dead) 2.1±0.44
Apoptotic (% TUNEL positive) 1.3±0.65
Total proteoglycan
% wet weight 1.1±0.26 4.6±0.83 1:4
% dry weight 15.4±5.41 18.8±1.50 1:1.2
mg/wet weight 1.02±0.21
Total collagen
% wet weight 1.4±0.32 18.4±1.03 1:13
% dry weight 19.0±6.49 76.5±3.56 1:4
mg/wet weight 1.3±0.33
†From similar wet weights.
‡Significant difference between the number of cells located centrally compared with those located peripherally (P<0.001).
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in two of the five constructs examined (0.1±0.03) and
versican only faintly registered in one construct
(0.04±0.03).
Discussion
We provide evidence that the tissue produced in the
reported scaffold-free system has cartilage-like qualities in
terms of production of collagen type II, the deposition of
ECM largely consisting of glycosaminoglycans, and the
evidence of collagen fibril and interterritorial region forma-
tion. After 4 weeks of culture, the constructs produced
were highly viable, stable enough to be handled by
surgical forceps and were regular in form. This closed
system appears to create the conditions required for
chondrogenesis, namely the maintenance of close cell
contact in three-dimensions and allows the accumulation of
matrix macromolecules within a period of 3–4 weeks. The
membrane cut-off size in the chamber reported in this
study is 100 kDa, which is apparently small enough to
permit the exchange of nutrients and waste products, as
reflected in their high viability [Fig. 1(B)], but is adequately
small to prevent macromolecules such as aggrecan
(200–300 kDa)31, for example, from migrating out of the
chamber. In comparison with cartilaginous constructs of
other reports, our cartilaginous constructs were somewhat
immature as the amount and proportion of collagen and
proteoglycan produced were much lower3,32–34.
As it appears that the 100 kDa membrane and the static
conditions are sufficient for viable cartilage formation, this is
in contrast to the idea of a necessary dynamic media
exchange made possible by using more complicated
perfusion systems. Minuth et al.25 stated that perfusion
culture systems remove potentially damaging metabolites
or paracrine factors compared with static environment
cultures. However, it may be argued that some paracrine or
other required factors might be removed by a perfusion
system. Indeed, Cao et al.9 observed that a complete
change of media induces severe apoptosis. These investi-
gators provided evidence that the ECM molecules, such as
collagen, present in the culture media provide vital
chondrocyte–matrix interactions and when the entire media
is changed, the cells are deprived of this matrix molecule
and undergo programmed cell death. Freed et al.33 pro-
posed that “the relatively slow diffusion of chemical
species into the interior of the construct has not been an
overwhelming problem in the engineering of cartilage, an
avascular tissue that can be cultured in bioreactors to a
thickness of at least 5 mm.” This is consistent with the type
of viable construct produced in this study’s static system, at
least over a 4-week culture period. Meredith et al.35 sug-
gested that in addition to regulating cell growth and differ-
entiation, the ECM also functions as a survival factor for
many cell types. Therefore, the ‘closed’ chamber used in
the present study may protect cells from losing these
essential ECM products.
The ECM of cartilage must contain a sufficient concen-
tration or density of hydroscopic matrix molecules (proteo-
glycans) that are of importance for the pressure resistance
of the cartilage36. Articular cartilage regions with superior
mechanical resistance have the highest proteoglycan
Fig. 3. SDS-PAGE gel analysis showing collagen subtypes found
in engineered neo-cartilage.
Fig. 4. Semi-quantitative RT-PCR showing the expression level (mean±standard error) of selected cartilage specific genes of interest relative
to GAPDH expression.
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concentration36,37, and the proportion of proteoglycans
produced here was 25% of that established in the native
cartilage source (Table II). Still, it appears that this propor-
tion of proteoglycans is adequate to firstly provide the
required stability to be handled by surgical instruments and,
as we have previously reported, the stability to remain
intact once implanted into an articular defect in the in vivo
environment38. Although it has been demonstrated that
physical stimulation enhances chondrogenesis and the
production of GAG and dynamic compression39–41, it is
perhaps not necessary to use complicated tissue culture
conditions if a static condition is adequate to produce an
implant that has been demonstrated to survive and repair
an articular defect. Yet, the use of systems that impose
physical stimulation to mimic the in vivo environment may
be useful to study the processes involved in chondro-
genesis, especially when choosing not to employ an animal
model.
The constructs produced here, like other systems, lack
cellular polarisation, fibril orientation and cell organisation.
Long-term in vitro cell culture does not give rise to high
functional organisation of ECM, most probably due to the
lack of specific biochemical and physical factors naturally
present in the in vivo environment4. We have previously
observed re-modelling of implanted cartilaginous tissue
produced from this system after 4 weeks in the minipig
following implantation38 and, thus, propose that in vivo
environmental cues are ideal for correct tissue structure.
Without the need for a scaffold, the reported system may
represent an advantage over existing technologies that
employ them. The use of resorbable compounds made up
of polylactic acid (PLLA) and polyglycolic acid (PGA), for
example, are reported to release α-hydroxy acids in high
local concentrations during breakdown, which may damage
the generated tissue by increased acidification20. Although
PGA scaffolds have been found to be toxic, alternatives like
PLLA are reported to have reduced toxic traits compared
with PGA in studies that report the maintenance of a
constant pH over 12 days or longer20,42. Biocompatibility of
the artificial ECM, especially autologous transplants, is a
major issue25. For instance, some forms of alginate have
been found to be immunogenic, increasing lymphocyte
activity and stimulating the production of anti-alginate
antibodies43,44. Nevertheless, in the bioreactor system
reported in the present study, a large number of cells are
required, which is a disadvantage, especially with the
limitation of cells derived from a biopsy and the problems
related to substantial cell culture expansion45,46. This dis-
advantage, however, may be overcome by the addition of
certain growth factors on expansion, which is within the
scope of our present research.
In most instances when cells are seeded into scaffolds,
the majority are located in the outer regions and then
migrate into the central areas. Freed et al.33 described this
phenomenon after 12 days of seeding PGA scaffolds.
However, the cells were evenly distributed throughout the
biomaterial after 40 days. The advantage of the system
reported in the present study therefore eliminates such
time-dependent variables and may even reduce a pro-
longed dedifferentiated state. It is presumed that scaffold-
seeded chondrocytes would need to dedifferentiate in order
to expand and colonise the inner regions of such a scaffold
system.
Implant maturity at the time of in vivo implantation is an
unresolved issue that needs to be explored. What actually
constitutes a mature implant? What are the minimum
biophysical requirements of an implant that will allow it to
survive and integrate with the surrounding native cartilage
for effective long-term cartilage repair? It is clear that long
term in vivo culture, with the appropriate stimuli, will lead to
neo-cartilage tissue possessing biochemical constituents
close to that of native cartilage33. However, long-term
in vitro cultured tissue equivalents have problems in
adequately integrating with the neighbouring cartilage
when implanted. Nevertheless, in vitro studies have dis-
played an improved integration of engineered and native
tissue when using constructs at an early stage of chondro-
genesis or maturity4,47. The notion of using the in vivo
environment as a ‘natural bioreactor’ has been classically
demonstrated by Brittberg et al.48 in the approach of
autologous cultured chondrocyte transplantation. Peterson
et al.49 have reported clinically satisfactory results in
follow-up studies after such treatment. The approach
employing the immature cartilage presented here is
‘in-between’ the spectrum of available approaches, since it
takes advantage of implanting a readily handled implant
without the need of a scaffold and avoids undesirable traits
of biomaterials. The screening of cell and implant quality is
also easier to accomplish with the immature de novo
implant. Indeed, we have provided evidence that such
immature implants may actually be an alternative in
articular cartilage repair in in vivo experiments with
minipigs38.
At least for a short period (3–4 weeks), cartilage con-
structs are viable and, as mentioned earlier, can be
implanted into an in vivo environment for further develop-
ment: using the animal as a bioreactor. Nevertheless, for
long-term viability in vitro, a perfusion system may be
required to ensure high cell viability. Longer-term studies
may also require additional conditions, such as mechanical
stimulation and the provision of greater or enhanced nutri-
ent exchange as the construct matrix matures. An in vitro
system that is able to mimic the in vivo environment may be
a useful tool in the systematic and controlled studies of
chondrogenesis, especially with regard to its initiation
and to identify specific factors that influence cartilage
regeneration and repair33.
This simple, static and closed bioreactor system is able
to create a condition that permits chondrogenesis and
subsequent immature cartilaginous constructs that are
highly viable, are regular in form and are of a convenient
shape for surgical procedures. Although no biomechanical
studies have been conducted at this stage, constructs
produced from this system have been demonstrated to
survive and even remodel after implantation38. A combina-
tion of various biomaterials and the presented technology
also opens the possibility to produce biphasic implants,
which may allow for better implant integration.
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